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Abstract
Hydatid disease is a frequently encountered entity in endemic areas and constitutes a serious health problem. The lung
is the second most commonly affected organ after the liver. In three of four cases of pulmonary hydatid cyst, the cyst is
solitary. The early phase after primary infection is always asymptomatic. Primary symptoms in patients with
pulmonary cystic echinococcosis include cough, fever, and chest pain. The clinical and radiological manifestations for
the hydatid cyst in the lung depend on the integrity of the cyst. Bronchial fistulization is an important event in the
evolution of the cyst. In cases of dubious orientation after the initial study, ultrasonography, conventional tomography,
and magnetic resonance imaging prove helpful in delineating the disease accurately. For a specific serologic diagnosis,
the immunoglobulin G enzyme-linked immunosorbent assay and immunoelectrophoresis are preferred. Despite the
efficacy of new chemotherapeutic regiments, the mainstay of treatment for thoracic hydatidosis remains essentially
surgical. In general chemotherapy is used as a complement to surgical treatment to avoid recurrence of the disease.
Regardless of the surgical methods adopted, the removal of the parasite intoto, prevention of its dissemination,
maximum preservation of pulmonary function, and the immediate obliteration of the remaining cavity are the
imperative basis for effective therapy. The most frequent post-surgical complications are pleural infection and
prolonged air leakage. The operative morbidity and recurrence rates have been reported with variation. Education of
the population in endemic areas regarding the disease transmission cycle and institution of appropriate prophylaxis are
essential steps to eradicate the disease completely.
Keywords: Thoracic hydatidosis; Lungs; Treatment; Diagnosis; Radiology
Introduction
Hydatid disease of the thorax is caused by the cestode
Echinococcus granulosus. The disease has been
known since the times of Galen, being described by
Thebesius in the 17th century [1, 2]. Over the years,
thoracic echinococcosis has been increasingly recognized as an important cause of mortality and morbidity
in susceptible populations. Its wide geographic
distribution and amenability to primarily surgical
treatment are important considerations. In this review,
we discuss the epidemiology, life cycle, clinical and
radiographic features, laboratory investigations and
treatment modalities for thoracic hydatidosis.

countries, New Zealand, Australia, North America,
South America, Central America, and Asia [2]. The
distribution of Echinococcus granulosus is influenced
by agricultural, economic, and educational levels, and
cultural habits [3]. For the developing world, this has
important implications because rural inhabitants in
these areas live under poor sanitary conditions [2].
The annual incidence of the disease ranges from less
than 1 to 220 per 100,000 inhabitants of various
endemic areas [3].

Epidemiology

The life cycle of the tapeworm includes synanthropic
and sylvatic cycles. Humans act as accidental intermediate hosts for the Echinococcus granulosus. The
adult tapeworm stage is harbored in the small intestine

Life Cycle of Echinococcus granulosus

Hydatid disease is found worldwide; being frequently
encountered in endemic areas such as Mediterranean
42

effects of the growing cyst cause cough, hemoptysis,
pneumothorax and pleuritis. Rupture with spillage of
the contents of the cyst leads to hypersensitivity
reactions such as anaphylaxis. Superinfection of the
cyst causes signs and symptoms of infection and is an
urgent indication for surgical intervention [14, 15].
Irrespective of the organ affected, most patients
with cystic ecchinococcosis, have single organ
involvement with solitary cysts. Simultaneous involvement of two or more organs is observed in 10% to
15% of patients, depending on the geographic origin
of the patient and the strain of the parasite,
respectively. Approximately, 10% of hepatic cystic
ecchinococcosis cases occur in children, whereas the
rate of lung infection is significantly increased among
this group of young patients and may reach 50% [16].

of a carnivore, (e.g. dogs, coyotes and wol- ves) called
the definitive host. The tapeworm eggs are passed in
the feces of infected carnivore and are ingested by
herbivores (e.g. sheep, cattle and goats) called the
intermediate host. The eggs hatch in the intestine of
the herbivore, penetrate the mucosal wall and reach
the liver via the portal circulation, where they develop
into hydatid cysts. Sometimes, they pass through the
liver barrier and reach the lungs and virtually any
other organ of the body. Humans are affected if they
ingest food or water contaminated with feces of
definitive host containing the eggs of Echinococcus
granulosus [2, 4]. Figure 1 shows the life cycle of
Echinococcus granulosus.
Thoracic Hydatid Cyst Disease
The lung is the second most commonly affected organ
after the liver [5]; being infected in 10-40% of the
cases [6]. The hydatid cyst can develop anywhere in
the lung, but it settles more often on the right side and
has a predilection for the lower lobe [6-8]. Its size can
range from a few centimeters to giant hydatid cysts
that can occupy the whole hemithorax [9]. There is no
universally accepted size to define a pulmonary
hydatid cyst as “giant”; however, 10 centimeters
seems an appropriate length in that it equals nearly
half of the hemithorax of most patients [10, 11].

Imaging the Hydatid Cyst
Before bronchial rupture, the typical image of a simple
cyst (intact, close, hyaline) is that of a homogenous
opacity, round with definite edges, situated in the
pulmonary field itself, or apparently implanted on the
liver, heart, or rachis [17]. The entrance of air between
hydatid cyst and adventitia through bronchiopericystic
fistula allows a perivesicular pneumocyst, air
meniscus, or crescent sign.
At the time of bronchial rupture, the radiological
examination often shows an important parenchymatous reaction, not only homolaterally but also
contralaterally. There is a diffuse dense opacity on the
cyst’s side; on the opposite sides the opacities are less
dense, less homogenous, and less limited, which is
related to pulmonary hydatid anaphylaxis. It disappears in 4 to 5 days, revealing the original cystic image
with its modifications. After the bronchial rupture, the
images are highly varied. The parasitic membrane,
partially detached from adventitia, creates a bridge
over the fluid: Ivanissevich’s double arch’s sign or
Jaubertand Brun’s double outline (two superposed
gaseous areas, one intracystic and other intraadventitial, separated by parasitic membrane) [17]. The
cystic membrane drops, floating on the surface of the
residual fluid and giving the Belot’s sign of floating
membrane or Lagos Garcia and Segars’ sign of the
water lily or camalote. A cyst that perforates into the
pleural cavity can appear with radiological signs of a
hydrothorax or a hydropneumothorax. With multiple
primary ecchinococcosis, radiology reveals cysts of
different sizes and configurations in one or both lungs.
With bronchogenic secondary ecchinococcosis, the
cysts are normally bilateral. Secondary metastatic
ecchinococcosis manifests as numerous small round
opacities that are bilateral and generally symmetric.

In three of four cases, the cyst is solitary. Multiple
cysts (either primary or secondary) can be unilateral or
bilateral. Ayetac et al. reported that 72% of their cases
had single cysts, 15% had multiple unilateral cysts,
and 13% had multiple bilateral cysts [12].
Factors Affecting Growth of Hydatid Cyst
The growth rate of the parasite changes with the
degree of host sensitization and tissue influences [10].
In the liver, the compact tissue and the hepatobiliary
capsules limit the cysts growth but the low resistance
of the lung provides an excellent medium for rapid
growth of hydatid cysts. The patient’s immune response to the parasite and early symptoms during the
illness prevent the cyst from growing in an unlimited
fashion [10].
Clinical Features of Thoracic Hydatid Cyst Disease
The early phase after primary infection is almost
always asymptomatic. Depending on the size and site
of the developing hydatid cyst, the infection can
remain asymptomatic for months, years, or even
longer. In the general population, the overall prevalence of asymptomatic cysts in the liver (2.5%) was
found to be much higher than that of cysts in the lung
(0.3%), giving a ratio of liver infection: lung infection
of 8.3:1. In the symptomatic cases, however, the ratio
was only 2.5:1 (based on hospital records) or
4.1:1(based on autopsy records) [13].
After a highly variable incubation period, the
infestation may become symptomatic because of a
range of different events. For example, pressure

Other Imaging Modalities
In cases of dubious orientation after the initial study,
the data facilitated by ultrasonography, conventional
tomography, and magnetic resonance imaging are
most interesting [18]. These methods can reveal
certain details of the lesions and discover others that
are not visible by conventional radiography. CT scan
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In patients with recurrence before 2 years, antibody
production remains at a level similar to that seen
preoperatively [26].

can also visualize signs of onset of complications,
such as incipient membrane detachment of small
bubbles located in the cyst wall [18]. MRI allows
reliable differentiation because the cyst has low signal
intensity on T-1 weighted images and high signal
intensity on T-2 weighted images [14]. For pulmonary
sites, ultrasound examination is unhelpful in most
cases, but sometimes it can confirm the cystic nature
of the parenchymatous mass that is juxtaparietal [19].
Hepatic ultrasound should be used routinely for
diagnosis of associated hepatic involvement as the two
entities can coexist.

Treatment of Thoracic Hydatidosis
Every pulmonary hydatid cyst that is identified must
be treated.
1. Medical Treatment
The treatment is essentially surgical, despite the
efficacy of new chemotherapeutic regimens advocated
by some quarters [35]. Dogan et al. noted that after
applying mebendazole 4 of 28 patients had to undergo
urgent operation owing to massive hemoptysis [36]. In
general chemotherapy is used as a complement to
surgical treatment to avoid recurrence. It is applied
preoperatively to prevent the consequences of possible
rupture of the cysts during surgery and postoperatively
as adjuvant therapy of the cysts that ruptured during
the operation. It is also suitable for patients with
multiple cysts, where in vitro studies of the parasite
show high fertility and viability and patients who
cannot undergo surgery [37]. Two benzimidazole
compounds (mebendazole and albendazole) and praziquantel have activity against Echinococcus granulosus
in vitro and in animal models [38, 39]. No controlled
studies have ever been performed in humans so far.
Albendazole seems preferable to mebendazole because of its better bioavailability. [40, 41] Both drugs
penetrate into the cysts [42, 43], but sometimes heroic
doses are needed to achieve a therapeutic plasma
concentration of mebendazole [44]. The generally
accepted therapeutic levels are approximately 250
nmol/L. The former use of albendazole in cycles of 4
weeks, followed by a drug-free interval of 2 weeks,
has been replaced more frequently with a continuous
treatment [45, 46]. In a small comparative study, all
six patients on continuous therapy showed cyst
involution, whereas relapse occurred in the cycling
group [47].

Laboratory Diagnosis of Hydatid Cyst Disease
If aspiration cytology is performed, trichromic
staining of the filtrated aspirate reveals acid fast
hooklets [20]. Cytology seems particularly helpful in
detecting pulmonary involvement [21]. Viability of
aspirated protoscolices can be determined by
microscopic demonstration of flame cell activity and
Trypan Blue dye exclusion. Laboratory diagnosis of
cystic hydatid disease is complementary to the clinical
data [22]. For closed cysts whose membrane begins to
exfoliate or open ones where the cuticular layer has
been fragmented, the true diagnosis is occasionally
provided by the microscopic discovery of cuticular
remnants or hooklets in expectorated material. The
eosinophilia and precocious positivity of Casoni’s
intradermal reaction were at one time helpful
elements, despite their variable sensitivity and limited
specificity [23-25].
In the most recent experience, the most sensitive
technique was the specific immunoglobulin G (IgG)
ELISA test [26]. However, for pulmonary cyst
localization, the diagnostic sensitivity is lower than
that of hepatic cases. These tests are generally used for
primary serological screening. Specificity of such tests
increases considerably when using , for example, the
antigen 5- precipitation test (arc 5 test) or
immunoblotting for a relatively specific 8kD/12kD
hydatid fluid polypeptide antigen [27, 28]. The
demonstration of parasite specific IgE has attracted
particular attention because of its well known
relevance in helminthic diseases [29, 30] but has
exhibited no significant immunodiagnostic advantage
in cystic ecchinococcosis. There are also problems of
diagnostic sensitivity and specificity because of cross
reactions related not only to infections with
heterologous helminthic species but also to
malignancies [31, 32] and the presence of anti P1antibodies [33].
Monoclonal antibodies (MAbs) generated against
different parasite antigens have been used for the
diagnosis of cystic echinococccosis by detection of
circulating antigens in patients’ sera or of native
proteins in biopsies. Such MAbs have been directed
mainly against 2 major E. granulosus antigens: antigen
5 and antigen B [34]. The serological tests are also
useful for the postoperative follow up. The antibody
production rate shows an elevation during the first 4 to
6 weeks after the operation followed by a drop, more
or less abrupt, during the 12 to 18 subsequent months.

2. Surgical Treatment
Because there is great variability in the pathology
among pulmonary hydatid cysts, a uniform treatment
cannot be recommended. However, there are two
objectives:
1. To remove the parasite; and
2. To treat bronchio-pericystic pathology and other
associated lesions.
Therefore, modern surgical treatment must be
individualized for each case. Regardless of the
surgical methods adopted, the removal of the entire
parasite, prevention of its dissemination, maximum
preservation of pulmonary function, and the immediate obliteration of the remaining cavity are the basis
for effective therapy.
In most cases in intact cysts, simple removal fulfills
all these requirements and certainly is the ideal
approach. The host membrane is widely opened by a
44
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Figure 1. Schematic life cycle of Echinococcus granulosus (Redrawn from F.L Andersen, A.G. Barbour, F.J.
Schoenfeld, Proceedings of 78th Meeting of United States Animal Health Association 78:370, 1974)
It is generally agreed, however, that the most
important point in the management of the residual
pericystic cavity is closure of patent bronchial
openings. Saidi [51] pointed out that approximating
and suturing cavity edges is not necessary because the
pulmonary parenchyma obliterates the space, and the
surface of the lung at the site of residual cavity is
covered by pleura.
If intraoperative pleural contamination occurs,
flooding the cavity with scolicidal agents is
worthwhile. Hypotonic (distilled water) or hypertonic
(10% saline) solutions, or 10% formaldehyde solution
may be employed. The potential complications
associated with spillage of hydatid cysts include
anaphylactic shock, pleural contamination with
resulting secondary hydatidosis, and contralateral
bronchial dissemination. The routine use of doublelumen endotracheal tubes or bronchial blockers avoid,
during manipulation of the effected lung, hydatid
material going into the bronchial tree [56].

short incision that surrounds the most superficial part
of the cyst in the visceral pleura. Until hemostasis is
secured, the enucleation method, originally described
by Ugon [48] and Barret [49], is the most adequate
technique to remove intact small and medium
pulmonary cysts. Peschiera [50] suggested that the
live contents should initially be evacuated to prevent
the risk of contamination by rupture of the cyst during
removal. During evacuation of the contents of large
cysts, a scolicidal solution is used to avoid
contamination of operative field. Formaldehyde
solution or pure formaldehyde has been suggested by
many authors, but leakage of these substances is
harmful to the pericystic tissues and therefore
interferes with the healing process and increases the
incidence of bronchopleural fistula [51]. The use of
hypertonic saline is less harmful to the tissues and is
recommended by many surgeons [52].
After the removal of the cyst, the remaining cavity can
be treated in a variety of ways. In 1948, Perez-Fontana
[53] from Uruguay suggested the resection of host
membrane, pericyst, with the intact cyst, as routine to
prevent infectious complications that result from
residual cavities with walls that are too thick to
collapse spontaneously. The resection of the host
membrane identifies bronchial leaks into the parasitic
chamber. They are sutured, and then the cyst is closed
with a spiral suture that approximates the walls
surrounding the wound left in the pulmonary
parenchyma caused by the removal of the cyst and its
adventitia. In Perez-Fontana pericystectomy [53],
there is more bleeding and air leakage.
Regarding the management of cystic cavity in
complicated or intact cysts, Delbet [54] first described
the method called capitonnage, which is the folding of
the pericystic zones by sutures. Crausaz [55] reported
that purse-string sutures from the base of the pericyst
cavity upward could be used to obliterate the cavity.

3. Role of PAIR In Thoracic Hydatidosis
Puncture, aspiration, injection of a helminthicide, and
reaspiration (PAIR) have been propagated for hepatic
forms of hydatidosis. A meta-analysis comparing
clinical outcomes for hepatic cystic echinococcosis
found that the rate of clinical and parasitologic cure
(p=<0.0001) was greater in patients receiving
percutaneous aspiration-injection-reaspiration (PAIR)
plus chemotherapy (albendazole or mebendazole) as
compared to patients receiving surgical intervention.
However, this form of therapy was associated with a
higher rate of fever and minor allergic reactions as
compared to surgical intervention [57]. For pulmonary
hydatidosis, this technique is generally not indicated
[45].
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Int Arch Hydatidosis. 2001; 34:11-2.
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liver hydatidosis. Hepatogastro- enterology. 2000;
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Horcher E. Pulmonary echinococcosis (hydatidosis) in children: results of surgical treatment.
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17. Larbaoui D. Hydatid cyst of the lung. Rev
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18. von Sinner WN. New diagnostic signs in hydatid
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Results of Treatment
The operative morbidity has been variably reported in
different studies. [10, 25, 58] The most common
complications are pleural infection and prolonged air
leakage; seen in 2.54% and 2.19% cases respectively.
[23] Operative mortality, in general, today does not
exceed 1% to 2%. The nature of intervention is a less
important factor than the general condition of the
patient, the characteristics of the cyst(s), the degree of
repercussion on the remaining parenchyma, and the
associated lesions.
Recurrence of Disease
The recurrence rate is also variable; commonly
ranging between 1.5% to 2.5% [59]. Chevret et al.
[60] reported a series of 1397 pulmonary hydatid
cysts, with 7 early recurrences successfully operated
on and 34 late recurrences with a more than 3-year
disease-free interval. The early recurrences were
attributed to a lack of knowledge of incipient
microcysts and the later ones to re-infestations. The
authors thought that removal of the whole cyst, an
excellent intervention surgically speaking, did not
allow specific immunity to develop, so the individual
was prone to re-infestation. In 14 patients, the
recurrence was literally explosive from a true
confluence of bilateral cysts, leading to death from
respiratory failure.
It remains unclear how to proceed in case of
asymptomatic patients detected at screening or with
imaging for unrelated medical problems. In one small
series of 28 patients followed for more than 10 years,
75% of patients remained free of symptoms [61].
Conclusions
Despite the low mortality and limited recurrence rate,
thoracic hydatid disease imposes an important disease
burden in endemic areas. Some of the complications
of the disease can be potentially devastating.
Prophylaxis is therefore warranted. [6] Measures for
preventing hydatidosis, theoretically easy to
formulate, are regretfully difficult to apply, especially
in countries with a high hydatid prevalence rate. This
is most likely due to a lack on awareness of the
disease in the populace. The sources of infestation
must be suppressed or sterilized, and the chain of
transmission of the parasite must be interrupted. The
population must therefore be widely informed through
carefully tailored campaigns.
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